QuidelOrtho Maintenance and Reagents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
75D30125Q78789
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
Q301
Additional Details
Documents2
The Centers for Disease Control and Prevention (CDC), through its Office of Acquisition Services, has issued a combined synopsis/solicitation for the procurement of maintenance services and reagents specifically for the VITROS 3600 systems utilized by the Division of Viral Hepatitis Laboratory Branch. This procurement, identified under solicitation number 75D30125Q78789, is structured as a sole source, firm-fixed-price purchase order to be awarded to QuidelOrtho Corporation, the original equipment manufacturer (OEM) located at 9975 Summer Ridge Road, San Diego, California. The procurement falls under the authority of FAR 13.106-1(b)(1)(i) and is valued below the Simplified Acquisition Threshold (SAT), leveraging simplified acquisition procedures as outlined in FAR Part 13.
The primary purpose of this procurement is to ensure the uninterrupted operation and manufacturer-compliant maintenance of the VITROS 3600 systems, which are critical to the CDC’s viral hepatitis laboratory operations. The scope of work encompasses comprehensive OEM support services, including annual preventive maintenance, field application support, and the provision of all necessary software and hardware updates. Additionally, the agreement mandates the availability of technical support via email and phone during standard business hours (Monday through Friday) for the duration of the contract. The service agreement is designed to cover all repairs, replacements, and labor costs associated with instrument failures, ensuring that the laboratory’s diagnostic capabilities remain fully operational and compliant with manufacturer specifications.
Key requirements and deliverables include:
- Annual preventive maintenance performed by OEM-certified personnel
- Field application support to address operational and technical issues
- Inclusion of all software and hardware updates as released by the manufacturer
- Business hours technical support via email and phone for the life of the agreement
- Full coverage of repairs, replacements, and labor due to instrument failures
The procurement is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with no set-aside restrictions, and is open to the only known qualified source—QuidelOrtho Corporation—due to the proprietary nature of the equipment and required reagents. The place of performance is specified as 1600 Clifton Rd, Atlanta, GA 30329, Roybal campus, Building 18, 4th floor, Room 4-605, in the state of Georgia.
The CDC has determined that QuidelOrtho Corporation is the sole provider with the requisite access to proprietary diagnostics, reagents, and service infrastructure necessary to maintain the VITROS 3600 systems in accordance with manufacturer standards. While this is a sole source procurement, the CDC will consider responses from other interested parties received within fifteen (15) days of the notice posting. Any such responses should clearly demonstrate the capability to meet all specified requirements and must be submitted by 12:00 PM EST on Monday, January 26, 2026, referencing the RFQ number provided.
The contracting activity is managed by the CDC Office of Acquisition Services, with Gary Morgan ([email protected], 770-488-2639) as the primary contact and Liubov Kriel ([email protected], 770-488-2856) as the secondary contact. The procurement is posted as an open market opportunity, but due to the unique OEM requirements, only QuidelOrtho Corporation is currently recognized as a qualified offeror.
This notice is not a request for competitive quotations; however, all timely responses will be evaluated to determine if a competitive procurement is warranted. The government reserves sole discretion in making this determination. Contractors interested in this opportunity should carefully review the requirements and consider their ability to provide OEM-level support and proprietary reagents for the VITROS 3600 systems.
For further details and to access the official notice, interested parties may refer to the SAM.gov opportunity ID a80f89919b3c42babd61fa4d52be52bc.